Michael Smedley's top pick: Michael Smedley is executive vice-president and chief investment officer of Morgan Meighen & Associates. His focus is Canadian equities.
Top Picks:
Concordia Healthcare (CXR.TO)
Concordia has undertaken a game-boosting giant acquisition that appears riskless, except for a reasonable opportunity of paying down sizable debt over the next four years. It could easily replace Valeant as the top health-care stock in Canada.